NFKB1 and central nervous system cancer: Applying gliomas as an experimental model for network analyses, it was observed that NF-κB signaling pathway dysregulation was 1 of 4 signaling mechanisms whose perturbation was slightly satisfactory to maintain the phenotype of malignant glioma (Karlebach and Shamir, 2010).